|
Profile
|
Delegates :
Dr. Hiroyuki Takamatsu |

|
Incorporated :
November 1 , 2005 |
Paid in Capital :
70 Million yen |
Employees :
30 人 |
Address :
1-3-7 Shin-Miyakoda, Kita-ku, Hamamatsu SHIZUOKA
〒4312103
|
TEL/FAX :
+81-53-543-4543 / +81-53-543-6444 |
URL:
http://www.hpharmausa.com |
Attachment :
HPR_CompanyOverview.pdf [ 1.8MiB ] |
Mission/Background :
Mission We support translational research and accelerate our partners’ success: Hamamatsu Pharma Research (HPR) offers translational research innovations through preclinical efficacy evaluation of novel therapeutics in nonhuman primate (NHP) disease models.
Core Business Preclinical evaluation of potential therapeutic candidates intended for clinical testing
|
Technology & Business
|
[Pharmacological studies] Pain: Capsaicin-induced acute pain, Osteoarthritis, postoperative pain,Oxaliplatin-induced neuropathic pain Stroke: Photochemically-Induced Thrombosis (PIT), Thromboembolic occlusion, permanent/temporary Other areas: Gastrointestinal disorders (IBD) Cardiovascular disorders (Thrombosis) Neurological disorders (Parkinson's disease) Ophthalmology (Age-related macular degeneration: wet and dry AMD) Endometriosis
[Non-invasive in vivo Imaging: fMRI, CT and PET] Non-invasive imaging of NHPs is available through an exclusive agreement with Hamamatsu University School of Medicine. We have a full access to a state-of art imaging facility equipped with fMRI, CT and PET.
[Disease model customization / development] Individual, as-needed pharmacological model optimization
[Consultation] Study design and conduct centered around NHP
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
Pharmacological Studies using Nonhuman Primates
|
Preclinical
|
Preclinical efficacy evaluation of potential therapeutic cacndidates
|
Assisting translational research innovations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Highlights
|
[Publications & Scientific Presentations] https://www.hpharmausa.com/publications
[Accreditation] Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC) (Unit 001564 on June 19, 2015)
|
Alliance strategy
|
We are also very interested in collaborations with industric and academic organizations. Feel free to ask us any concerns about your preclinical studies!
|
|
|